Search Results 581-590 of 15110 for alt

  1. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  2. Metabolic syndrome - Symptoms & causes - Mayo Clinic

    Having three or more specific risk factors, such as high blood pressure or abdominal fat, boosts your risk of type 2 diabetes and heart disease.

  3. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

  4. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    AST or ALT >5 times UNL; For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis ...

  5. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  6. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma - Mayo Clinic

    ... [ALT]) ≤ 135 U/L. Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L. Shortening fraction of ≥ 27% by ...

  7. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    ALT ≤1.5 x ULN. Total bilirubin within institutional normal limits. Creatinine ≤1.5 x ULN. Exclusion Criteria: Current or previous evidence of muscle ...

  8. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial - Mayo Clinic

    ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

  9. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

    ... (ALT) has been set to the value of 45 U/L * Shortening fraction of ≥ 27% by echocardiogram, or * Ejection fraction of ≥ 50% by radionuclide angiogram * No ...

  10. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 2.5 x ULN; concomitant elevations in bilirubin and AST/ALT above 1.0 X ULN are NOT permitted; also ...